{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:16:47Z","timestamp":1788797807547,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.clgc.2017.02.004","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T02:39:42Z","timestamp":1488249582000},"page":"e747-e754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-2502","authenticated-orcid":false,"given":"Omar","family":"Abdel-Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2017.02.004_bib2","doi-asserted-by":"crossref","unstructured":"Abdel-Rahman O. Squamous cell carcinoma of the bladder: a SEER Database analysis [e-pub ahead of print]. Clin Genitourin Cancer http:\/\/dx.doi.org\/10.1016\/j.clgc.2016.10.007, accessed January 2, 2017.","DOI":"10.1016\/j.clgc.2016.10.007"},{"key":"10.1016\/j.clgc.2017.02.004_bib3","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1159\/000453198","article-title":"The clinicopathological significance of epigenetic silencing of VHL promoter and renal cell carcinoma: a meta-analysis","volume":"40","author":"Yang","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.clgc.2017.02.004_bib4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<640::AID-IJC4>3.0.CO;2-6","article-title":"Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family","volume":"82","author":"Olivero","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clgc.2017.02.004_bib5","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1200\/JCO.2010.30.9484","article-title":"Cigarette smoking is associated with advanced renal cell carcinoma","volume":"29","author":"Tsivian","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clgc.2017.02.004_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0065-230X(10)07002-8","article-title":"Obesity, cholesterol, and clear-cell renal cell carcinoma (RCC)","volume":"107","author":"Drabkin","year":"2010","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.clgc.2017.02.004_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/occmed\/52.3.157","article-title":"Renal cell carcinoma and occupational exposure to chemicals in Canada","volume":"52","author":"Hu","year":"2002","journal-title":"Occup Med (Lond)"},{"key":"10.1016\/j.clgc.2017.02.004_bib8","doi-asserted-by":"crossref","first-page":"e0143067","DOI":"10.1371\/journal.pone.0143067","article-title":"The incidence characteristics of second primary malignancy after diagnosis of primary colon and rectal cancer: a population-based study","volume":"10","author":"Guan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2017.02.004_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10549-015-3439-7","article-title":"Racial and ethnic differences in risk of second primary cancers among breast cancer survivors","volume":"151","author":"Calip","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clgc.2017.02.004_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/jech.38.1.85","article-title":"Simple exact analysis of the standardised mortality ratio","volume":"38","author":"Liddell","year":"1984","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1016\/j.clgc.2017.02.004_bib12","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","article-title":"Confidence intervals for the number needed to treat","volume":"317","author":"Altman","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.clgc.2017.02.004_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/15384047.2016.1167293","article-title":"Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family","volume":"17","author":"Yuan","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.clgc.2017.02.004_bib14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.clgc.2017.02.004_bib15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/1566524043359674","article-title":"Hereditary papillary renal carcinoma type I","volume":"4","author":"Dharmawardana","year":"2004","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.clgc.2017.02.004_bib16","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/hmg\/ddg148","article-title":"Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency","volume":"12","author":"Alam","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clgc.2017.02.004_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","article-title":"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle\u00a0in patients with the Birt-Hogg-Dube syndrome","volume":"2","author":"Nickerson","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clgc.2017.02.004_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/cncr.29025","article-title":"Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea","volume":"121","author":"Cho","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2017.02.004_bib19","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1089\/thy.2007.0171","article-title":"Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis","volume":"17","author":"Subramanian","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.clgc.2017.02.004_bib20","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1245\/s10434-011-2193-2","article-title":"Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study","volume":"19","author":"Lal","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clgc.2017.02.004_bib21","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1002\/cncr.30164","article-title":"Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008","volume":"122","author":"Donin","year":"2016","journal-title":"Cancer"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767317300472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767317300472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:28:30Z","timestamp":1761564510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767317300472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1558767317300472"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2017.02.004","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2017.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}